Darotropium bromideAlternative Names: 233705; GSK 233705
Latest Information Update: 25 Mar 2017
At a glance
- Originator GlaxoSmithKline
- Class Bronchodilators; Small molecules
- Mechanism of Action Muscarinic receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease